Summary and next episodes
SARCOMA CONNECT has summarised the highlights from ASCO 2019 for you. Soft-tissue Sarcoma, Osteosarcoma and GIST by Dr Robin L. Jones, Royal Marsden Hospital, Institute of Cancer Research, London, UK
Robin Jones is a medical oncologist specialising in the treatment of bone and soft tissue sarcomas and Head of the Sarcoma Unit at The Royal Marsden. He has experience in conducting Phase I, II and III trials, as well translational studies in sarcomas. Professor Jones trained in medical oncology at The Royal Marsden and between 2010 and 2014 he was Head of the Sarcoma Program at the University of Washington/Fred Hutchinson Cancer Research Center in Seattle. His main research interest focuses on clinical trials and translational research in sarcomas
Programme summary
-
Duration
5 MIN
-
Language(s)
Brought to you by
SARCOMA CONNECT is an initiative of COR2ED, supported by Independent Educational Grants from Bayer and Karyopharm Therapeutics.
Meet the experts
Other programmes of interest
Video podcast
Oncology
Metastatic TNBC cannot wait
Optimising 1st line TROP2 ADC decisions in metastatic triple-negative breast cancer
Experts
Prof. Giuseppe Curigliano, Prof. Javier Cortés-
Downloadable
Resources -
27 MIN
-
Oct 2026 -
Speed ReadInfographic / Flashcard
Oncology
Real-world outcomes of elacestrant in ER+/HER2−, ESR1-mutant metastatic breast cancer
Findings from the Komodo–Foundation Medicine real-world analysis
Experts
Dr Seth Wander-
Downloadable
Resources -
8 MIN
-
Oct 2026
Speed ReadVideo overview
Oncology Hemato-oncology
Optimising outcomes in multiple myeloma
Navigating resistance with innovative approaches
Experts
Dr Paula Rodríguez-Otero, Dr Joshua Richter, Dr Gabriele Buda-
Downloadable
Resources -
4 MIN
-
Oct 2026
Speed ReadVideo overview
Oncology
ROS1-positive NSCLC
Expert insights, from identification to next-generation therapy
Experts
Dr Maurice PérolEndorsed by
-
Downloadable
Resources -
7 MIN
-
Sep 2026
-
Speed ReadPublication Snapshot
Oncology
Exploring pan-RAS targeting beyond G12C in non-small cell lung cancer (NSCLC)
Putting recent daraxonrasib publication data into context
Experts
Prof. David Hong, Prof. Michael Duruisseaux, Dr Hidehito HorinouchiEndorsed by
-
Downloadable
Resources -
6 MIN
-
Sep 2026
-
Conference update
Episode
3
of 3
Oncology
How are new data shaping the landscape in HER2-mutant NSCLC?
Insights from WCLC 2026
Experts
Dr Joshua SabariEndorsed by
-
Downloadable
Resources -
5 MIN
-
Sep 2026
